vs
Genie Energy Ltd.（GNE）与Ultragenyx Pharmaceutical Inc.（RARE）财务数据对比。点击上方公司名可切换其他公司
Ultragenyx Pharmaceutical Inc.的季度营收约是Genie Energy Ltd.的1.5倍（$207.3M vs $138.3M），Genie Energy Ltd.净利率更高（4.9% vs -62.0%，领先66.9%），Ultragenyx Pharmaceutical Inc.同比增速更快（25.9% vs 23.6%），过去两年Ultragenyx Pharmaceutical Inc.的营收复合增速更高（38.0% vs 14.8%）
Genie Energy Ltd.是一家总部位于美国新泽西州纽瓦克的能源企业，作为控股公司，旗下业务涵盖零售能源、国际零售能源、能源服务以及油气业务，迈克尔·斯坦因现任该公司首席执行官。
Ultragenyx Pharmaceutical Inc.是一家总部位于美国的生物制药企业，专注于研发罕见病和超罕见遗传病的创新治疗方案，这类疾病目前大多无获批疗法，存在大量未被满足的临床需求。公司覆盖生物制剂、小分子药物、基因疗法、反义寡核苷酸及mRNA等多种药物技术平台，研发管线涵盖骨骼、内分泌、代谢、肌肉及中枢神经系统疾病领域。
GNE vs RARE — 直观对比
营收规模更大
RARE
是对方的1.5倍
$138.3M
营收增速更快
RARE
高出2.3%
23.6%
净利率更高
GNE
高出66.9%
-62.0%
两年增速更快
RARE
近两年复合增速
14.8%
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $138.3M | $207.3M |
| 净利润 | $6.7M | $-128.6M |
| 毛利率 | 21.7% | — |
| 营业利润率 | 5.0% | -54.7% |
| 净利率 | 4.9% | -62.0% |
| 营收同比 | 23.6% | 25.9% |
| 净利润同比 | -33.9% | 3.5% |
| 每股收益（稀释后） | $0.26 | $-1.28 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收GNERARE
| Q4 25 | — | $207.3M | ||
| Q3 25 | $138.3M | $159.9M | ||
| Q2 25 | $105.3M | $166.5M | ||
| Q1 25 | $136.8M | $139.3M | ||
| Q4 24 | $102.9M | $164.6M | ||
| Q3 24 | $111.9M | $139.5M | ||
| Q2 24 | $90.7M | $147.0M | ||
| Q1 24 | $119.7M | $108.8M |
净利润GNERARE
| Q4 25 | — | $-128.6M | ||
| Q3 25 | $6.7M | $-180.4M | ||
| Q2 25 | $2.8M | $-115.0M | ||
| Q1 25 | $10.3M | $-151.1M | ||
| Q4 24 | $-15.3M | $-133.2M | ||
| Q3 24 | $10.2M | $-133.5M | ||
| Q2 24 | $9.6M | $-131.6M | ||
| Q1 24 | $8.1M | $-170.7M |
毛利率GNERARE
| Q4 25 | — | — | ||
| Q3 25 | 21.7% | — | ||
| Q2 25 | 22.3% | — | ||
| Q1 25 | 27.3% | — | ||
| Q4 24 | 32.5% | — | ||
| Q3 24 | 33.9% | — | ||
| Q2 24 | 36.8% | — | ||
| Q1 24 | 28.2% | — |
营业利润率GNERARE
| Q4 25 | — | -54.7% | ||
| Q3 25 | 5.0% | -106.9% | ||
| Q2 25 | 1.9% | -64.8% | ||
| Q1 25 | 9.4% | -102.6% | ||
| Q4 24 | -20.2% | -74.3% | ||
| Q3 24 | 10.4% | -94.6% | ||
| Q2 24 | 11.6% | -79.1% | ||
| Q1 24 | 8.2% | -151.9% |
净利率GNERARE
| Q4 25 | — | -62.0% | ||
| Q3 25 | 4.9% | -112.8% | ||
| Q2 25 | 2.7% | -69.0% | ||
| Q1 25 | 7.5% | -108.5% | ||
| Q4 24 | -14.9% | -80.9% | ||
| Q3 24 | 9.1% | -95.7% | ||
| Q2 24 | 10.6% | -89.5% | ||
| Q1 24 | 6.8% | -156.8% |
每股收益（稀释后）GNERARE
| Q4 25 | — | $-1.28 | ||
| Q3 25 | $0.26 | $-1.81 | ||
| Q2 25 | $0.11 | $-1.17 | ||
| Q1 25 | $0.40 | $-1.57 | ||
| Q4 24 | $-0.58 | $-1.34 | ||
| Q3 24 | $0.38 | $-1.40 | ||
| Q2 24 | $0.36 | $-1.52 | ||
| Q1 24 | $0.30 | $-2.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $109.8M | $421.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $198.8M | $-80.0M |
| 总资产 | $394.1M | $1.5B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资GNERARE
| Q4 25 | — | $421.0M | ||
| Q3 25 | $109.8M | $202.5M | ||
| Q2 25 | $106.0M | $176.3M | ||
| Q1 25 | $118.3M | $127.1M | ||
| Q4 24 | $110.1M | $174.0M | ||
| Q3 24 | $141.8M | $150.6M | ||
| Q2 24 | $126.8M | $480.7M | ||
| Q1 24 | $106.9M | $112.3M |
股东权益GNERARE
| Q4 25 | — | $-80.0M | ||
| Q3 25 | $198.8M | $9.2M | ||
| Q2 25 | $197.0M | $151.3M | ||
| Q1 25 | $198.0M | $144.2M | ||
| Q4 24 | $190.5M | $255.0M | ||
| Q3 24 | $211.1M | $346.8M | ||
| Q2 24 | $202.1M | $432.4M | ||
| Q1 24 | $192.9M | $140.3M |
总资产GNERARE
| Q4 25 | — | $1.5B | ||
| Q3 25 | $394.1M | $1.2B | ||
| Q2 25 | $383.1M | $1.3B | ||
| Q1 25 | $384.4M | $1.3B | ||
| Q4 24 | $371.3M | $1.5B | ||
| Q3 24 | $341.7M | $1.5B | ||
| Q2 24 | $322.8M | $1.6B | ||
| Q1 24 | $328.3M | $1.3B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $13.9M | $-99.8M |
| 自由现金流经营现金流 - 资本支出 | — | $-100.8M |
| 自由现金流率自由现金流/营收 | — | -48.6% |
| 资本支出强度资本支出/营收 | — | 0.5% |
| 现金转化率经营现金流/净利润 | 2.07× | — |
| 过去12个月自由现金流最近4个季度 | — | $-472.0M |
8季度趋势，按日历期对齐
经营现金流GNERARE
| Q4 25 | — | $-99.8M | ||
| Q3 25 | $13.9M | $-91.4M | ||
| Q2 25 | $1.1M | $-108.3M | ||
| Q1 25 | $15.3M | $-166.5M | ||
| Q4 24 | $13.0M | $-79.3M | ||
| Q3 24 | $24.4M | $-67.0M | ||
| Q2 24 | $20.4M | $-77.0M | ||
| Q1 24 | $12.9M | $-190.7M |
自由现金流GNERARE
| Q4 25 | — | $-100.8M | ||
| Q3 25 | — | $-92.7M | ||
| Q2 25 | — | $-110.7M | ||
| Q1 25 | $13.6M | $-167.8M | ||
| Q4 24 | — | $-79.5M | ||
| Q3 24 | $21.9M | $-68.6M | ||
| Q2 24 | $20.1M | $-79.0M | ||
| Q1 24 | $11.7M | $-193.9M |
自由现金流率GNERARE
| Q4 25 | — | -48.6% | ||
| Q3 25 | — | -58.0% | ||
| Q2 25 | — | -66.5% | ||
| Q1 25 | 9.9% | -120.5% | ||
| Q4 24 | — | -48.3% | ||
| Q3 24 | 19.6% | -49.2% | ||
| Q2 24 | 22.1% | -53.7% | ||
| Q1 24 | 9.8% | -178.2% |
资本支出强度GNERARE
| Q4 25 | — | 0.5% | ||
| Q3 25 | — | 0.8% | ||
| Q2 25 | — | 1.5% | ||
| Q1 25 | 1.3% | 1.0% | ||
| Q4 24 | — | 0.1% | ||
| Q3 24 | 2.2% | 1.2% | ||
| Q2 24 | 0.4% | 1.4% | ||
| Q1 24 | 1.0% | 3.0% |
现金转化率GNERARE
| Q4 25 | — | — | ||
| Q3 25 | 2.07× | — | ||
| Q2 25 | 0.40× | — | ||
| Q1 25 | 1.49× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.39× | — | ||
| Q2 24 | 2.12× | — | ||
| Q1 24 | 1.59× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
GNE
| Sales Channel Directly To Consumer | $108.8M | 79% |
| Sales Channel Through Intermediary | $23.5M | 17% |
| Genie Renewables GREW | $6.0M | 4% |
RARE
| Royalty | $105.6M | 51% |
| Products | $101.7M | 49% |
